Diagnostic delay of sarcoidosis: an integrated systematic review.
Diagnostic delay
Meta-aggregation
Meta-analysis
Misdiagnosis
Rare disease
Sarcoidosis
Systematic review
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
11 Apr 2024
11 Apr 2024
Historique:
received:
23
03
2023
accepted:
28
03
2024
medline:
12
4
2024
pubmed:
12
4
2024
entrez:
11
4
2024
Statut:
epublish
Résumé
Sarcoidosis is a chronic inflammatory granulomatous disease of unknown cause. Delays in diagnosis can result in disease progression and poorer outcomes for patients. Our aim was to review the current literature to determine the overall diagnostic delay of sarcoidosis, factors associated with diagnostic delay, and the experiences of people with sarcoidosis of diagnostic delay. Three databases (PubMed/Medline, Scopus, and ProQuest) and grey literature sources were searched. Random effects inverse variance meta-analysis was used to pool mean diagnostic delay in all types of sarcoidosis subgroup analysis. Diagnostic delay was defined as the time from reported onset of symptoms to diagnosis of sarcoidosis. We identified 374 titles, of which 29 studies were included in the review, with an overall sample of 1531 (694 females, 837 males). The overall mean diagnostic delay in all types of sarcoidosis was 7.93 months (95% CI 1.21 to 14.64 months). Meta-aggregation of factors related to diagnostic delay in the included studies identified three categories: (1) the complex and rare features of sarcoidosis, (2) healthcare factors and (3) patient-centred factors. Meta-aggregation of outcomes reported in case studies revealed that the three most frequent outcomes associated with diagnostic delay were: (1) incorrect diagnosis, (2) incorrect treatment and (3) development of complications/disease progression. There was no significant difference in diagnostic delay between countries with gatekeeper health systems (where consumers are referred from a primary care clinician to specialist care) and countries with non-gatekeeper systems. No qualitative studies examining people's experiences of diagnostic delay were identified. The mean diagnostic delay for sarcoidosis is almost 8 months, which has objective consequences for patient management. On the other hand, there is a paucity of evidence about the experience of diagnostic delay in sarcoidosis and factors related to this. Gaining an understanding of people's experiences while seeking a diagnosis of sarcoidosis is vital to gain insight into factors that may contribute to delays, and subsequently inform strategies, tools and training activities aimed at increasing clinician and public awareness about this rare condition. PROSPERO Registration number: CRD42022307236.
Sections du résumé
BACKGROUND
BACKGROUND
Sarcoidosis is a chronic inflammatory granulomatous disease of unknown cause. Delays in diagnosis can result in disease progression and poorer outcomes for patients. Our aim was to review the current literature to determine the overall diagnostic delay of sarcoidosis, factors associated with diagnostic delay, and the experiences of people with sarcoidosis of diagnostic delay.
METHODS
METHODS
Three databases (PubMed/Medline, Scopus, and ProQuest) and grey literature sources were searched. Random effects inverse variance meta-analysis was used to pool mean diagnostic delay in all types of sarcoidosis subgroup analysis. Diagnostic delay was defined as the time from reported onset of symptoms to diagnosis of sarcoidosis.
RESULTS
RESULTS
We identified 374 titles, of which 29 studies were included in the review, with an overall sample of 1531 (694 females, 837 males). The overall mean diagnostic delay in all types of sarcoidosis was 7.93 months (95% CI 1.21 to 14.64 months). Meta-aggregation of factors related to diagnostic delay in the included studies identified three categories: (1) the complex and rare features of sarcoidosis, (2) healthcare factors and (3) patient-centred factors. Meta-aggregation of outcomes reported in case studies revealed that the three most frequent outcomes associated with diagnostic delay were: (1) incorrect diagnosis, (2) incorrect treatment and (3) development of complications/disease progression. There was no significant difference in diagnostic delay between countries with gatekeeper health systems (where consumers are referred from a primary care clinician to specialist care) and countries with non-gatekeeper systems. No qualitative studies examining people's experiences of diagnostic delay were identified.
CONCLUSION
CONCLUSIONS
The mean diagnostic delay for sarcoidosis is almost 8 months, which has objective consequences for patient management. On the other hand, there is a paucity of evidence about the experience of diagnostic delay in sarcoidosis and factors related to this. Gaining an understanding of people's experiences while seeking a diagnosis of sarcoidosis is vital to gain insight into factors that may contribute to delays, and subsequently inform strategies, tools and training activities aimed at increasing clinician and public awareness about this rare condition.
TRIAL REGISTRATION
BACKGROUND
PROSPERO Registration number: CRD42022307236.
Identifiants
pubmed: 38605384
doi: 10.1186/s13023-024-03152-7
pii: 10.1186/s13023-024-03152-7
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
156Subventions
Organisme : Department of Health and Aged Care, Australian Government
ID : ID 4-G5ZN0T7
Informations de copyright
© 2024. The Author(s).
Références
Baughman RP, Field S, Costabel U, Crystal RG, Culver DA, Drent M, et al. Sarcoidosis in America. Analysis based on Health Care Use. Ann Am Thorac Soc. 2016;13(8):1244–52.
pubmed: 27509154
doi: 10.1513/AnnalsATS.201511-760OC
Leclerc S, Myers RP, Moussalli J, Herson S, Poynard T, Benveniste O. Sarcoidosis and interferon therapy: report of five cases and review of the literature. Eur J Intern Med. 2003;14(4):237–43.
pubmed: 12919839
doi: 10.1016/S0953-6205(03)00078-5
Rybicki BA, Major M, Popovich J Jr., Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145(3):234–41.
pubmed: 9012596
doi: 10.1093/oxfordjournals.aje.a009096
Mirsaeidi M, Machado RF, Schraufnagel D, Sweiss NJ, Baughman RP. Racial difference in sarcoidosis mortality in the United States. Chest. 2015;147(2):438–49.
pubmed: 25188873
doi: 10.1378/chest.14-1120
Perlman DM, Sudheendra MT, Furuya Y, Shenoy C, Kalra R, Roukoz H, et al. Clinical presentation and treatment of high-risk Sarcoidosis. Annals Am Thorac Soc. 2021;18(12):1935–47.
doi: 10.1513/AnnalsATS.202102-212CME
Higgins JPTTJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 2021.
Pasadhika S, Rosenbaum JT. Ocular Sarcoidosis. Clin Chest Med. 2015;36(4):669–83.
pubmed: 26593141
pmcid: 4662043
doi: 10.1016/j.ccm.2015.08.009
Kidd DP. Neurosarcoidosis: clinical manifestations, investigation and treatment. Pract Neurol. 2020;20(3):199–212.
pubmed: 32424017
doi: 10.1136/practneurol-2019-002349
Bolletta E, Mastrofilippo V, Invernizzi A, Aldigeri R, Spaggiari L, Besutti G et al. Clinical relevance of Subcentimetric Lymph Node Biopsy in the diagnosis of ocular sarcoidosis. Ocul Immunol Inflamm. 2020:1–4.
Kusano KF, Satomi K. Diagnosis and treatment of cardiac sarcoidosis. Heart. 2016;102(3):184–90.
pubmed: 26643814
doi: 10.1136/heartjnl-2015-307877
Ungprasert P, Tooley AA, Crowson CS, Matteson EL, Smith WM. Clinical characteristics of ocular sarcoidosis: a Population-based study 1976–2013. Ocul Immunol Inflamm. 2019;27(3):389–95.
pubmed: 29023165
doi: 10.1080/09273948.2017.1386791
Johns CJ, Michele TM. The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital. Med (Baltim). 1999;78(2):65–111.
doi: 10.1097/00005792-199903000-00001
Hillerdal G, Nöu E, Osterman K, Schmekel B, Sarcoidosis. Epidemiology and prognosis. Am Rev Respir Dis. 1984;130(1):29–32.
pubmed: 6742607
Belperio JA, Shaikh F, Abtin FG, Fishbein MC, Weigt SS, Saggar R, et al. Diagnosis and treatment of pulmonary sarcoidosis: a review. JAMA. 2022;327(9):856–67.
pubmed: 35230389
doi: 10.1001/jama.2022.1570
Ungprasert P, Crowson CS, Matteson EL. Characteristics and long-term outcome of neurosarcoidosis: a Population-based study from 1976–2013. Neuroepidemiology. 2017;48(3–4):87–94.
pubmed: 28601860
doi: 10.1159/000477300
Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16(2):149–73.
pubmed: 10560120
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Reviews. 2015;4(1):1.
doi: 10.1186/2046-4053-4-1
McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 Guideline Statement. J Clin Epidemiol. 2016;75:40–6.
pubmed: 27005575
doi: 10.1016/j.jclinepi.2016.01.021
Namsrai T, Phillips C, Desborough J, Gregory D, Kelly E, Cook M et al. December,. Diagnostic delay of sarcoidosis: protocol for an integrated systematic review. PLoS ONE Accepted on 7 2022.
Veritas Health Innovation. Covidence systematic review software Melbourne, Australia [Available from: Available at www.covidence.org.
Hong QN, Fàbregues S, Bartlett G, Boardman F, Cargo M, Dagenais P, et al. The mixed methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers. Educ Inform. 2018;34:285–91.
doi: 10.3233/EFI-180221
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.
doi: 10.1186/1471-2288-14-135
pubmed: 25524443
pmcid: 4383202
RStudio Team. RStudio: Integrated Development for R. PBC, Boston MA. RStudio; 2020. http://www.rstudio.com/ .
Florczak KL. Meta-aggregation: just what is it? Nurs Sci Q. 2018;32(1):11.
doi: 10.1177/0894318418807933
Darugar A, Mathian A, Lehoang P, Bodaghi B. Acute posterior multifocal placoid pigment epitheliopathy as the initial manifestation of sarcoidosis. J Ophthalmic Vis Res. 2011;6(4):338–43.
pubmed: 22454756
pmcid: 3306121
Froehner M, Meinhardt M, Parmentier S, Hugo C, Wirth MP. Renal Sarcoidosis Mimicking Xanthogranulomatous Pyelonephritis. Urology. 2016;97:e19–20.
pubmed: 27590254
doi: 10.1016/j.urology.2016.08.031
Ghafoor A, Almakki A. Renal confined sarcoidosis: natural history and diagnostic challenge. Avicenna J Med. 2014;4(2):44–7.
pubmed: 24761384
pmcid: 3994709
doi: 10.4103/2231-0770.130346
Ghorpade A, Ramanan C. Cutaneous sarcoidosis. Indian J Dermatol Venereol Leprol. 1996;62(3):171–2.
pubmed: 20948028
Ho B, Choi KS, Ochoa W, Torralba KD, Sandhu VK, Pakbaz Z. Atypical manifestations of sarcoidosis in a hispanic male. J Community Hosp Intern Med Perspect. 2019;9(3):271–4.
pubmed: 31258873
pmcid: 6586134
doi: 10.1080/20009666.2019.1607503
Jaster JH, Dohan FC Jr., Bertorini TE, Bass JE, Mönkemüller KE, Handorf CR, et al. Solitary spinal cord sarcoidosis without other manifestations of systemic sarcoidosis. Clin Imaging. 1997;21(1):17–22.
pubmed: 9117926
doi: 10.1016/S0899-7071(96)00021-6
Lee CH, Jung YS, Lee SH. Hydrocephalus as a presenting manifestation of neurosarcoidosis: easy to misdiagnose as tuberculosis. J Korean Neurosurg Soc. 2010;48(1):79–81.
pubmed: 20717518
pmcid: 2916154
doi: 10.3340/jkns.2010.48.1.79
Mehta A, Khan F, Wagner C, Hashemzadeh T, Stemer A, Sloan EA, et al. A case of Neurosarcoid presenting as multiple intraparenchymal hemorrhages. Neurohospitalist. 2022;12(1):162–6.
pubmed: 34950407
doi: 10.1177/19418744211029495
Meyer N, Sutter R, Schirp U, Gutzeit A. Extensive intramuscular manifestation of sarcoidosis with initially missed diagnosis and delayed therapy: a case report. J Med Case Rep. 2017;11(1):246.
pubmed: 28835264
pmcid: 5569518
doi: 10.1186/s13256-017-1403-3
Noiles K, Beleznay K, Crawford RI, Au S. Sarcoidosis can present with necrotizing granulomas histologically: two cases of ulcerated sarcoidosis and review of the literature. J Cutan Med Surg. 2013;17(6):377–83.
pubmed: 24138972
doi: 10.2310/7750.2013.13035
Papaetis GS, Pefanis A, Solomon S, Tsangarakis I, Orphanidou D, Achimastos A. Asymptomatic stage I sarcoidosis complicated by pulmonary tuberculosis: a case report. J Med Case Rep. 2008;2:226.
pubmed: 18605996
pmcid: 2474644
doi: 10.1186/1752-1947-2-226
Plit ML, Miller GB. Cavitating pulmonary sarcoidosis. S Afr Med J. 1983;64(2):67–8.
pubmed: 6867879
Thomas PM, Mabrouk T, Li Y, Wallach SL. Delayed diagnosis in a Rare Case of Pulmonary Sarcoidosis presenting as unilateral Hilar Lymphadenopathy and Fever of unknown origin. Cureus. 2021;13(6):e15792.
pubmed: 34295598
pmcid: 8293858
van Rooijen JM, Mijnhout GS, Aalders TT, de Bondt RB. Hydrocephalus, a rare manifestation of sarcoidosis. Clin Pract. 2011;1(3):e66.
pubmed: 24765327
pmcid: 3981377
doi: 10.4081/cp.2011.e66
Viswanath L, Pallade S, Krishnamurthy B, Naveen T, Preethi BL, Pramod KP, et al. Darier-Roussy Sarcoidosis mimicking metastatic breast Cancer. Case Rep Oncol. 2009;2(3):251–4.
pubmed: 20737045
pmcid: 2914390
doi: 10.1159/000262412
Guleria R, Sharma R, Mohan A, Das C. Cardiac sarcoidosis: an uncommon presentation of sarcoidosis in India. Indian J Chest Dis Allied Sci. 2006;48(2):133–7.
pubmed: 16696528
Al-Mayouf SM, Al-Sonbul A, Al Jumaah S, Al-Hemidan A. Sarcoidosis: a delayed or missed diagnosis in children. Ann Saudi Med. 2006;26(3):220–3.
pubmed: 16861861
pmcid: 6074449
doi: 10.5144/0256-4947.2006.220
Fergie N, Jones NS, Havlat MF. The nasal manifestations of sarcoidosis: a review and report of eight cases. J Laryngol Otol. 1999;113(10):893–8.
pubmed: 10664703
doi: 10.1017/S0022215100145529
Judson MA, Vincent B, Huggins T, Silvestri GA, Sahn SA. Unusual presentations of pulmonary sarcoidosis: cases from the medical university of South Carolina. Semin Respir Crit Care Med. 2007;28(1):75–82.
pubmed: 17330193
doi: 10.1055/s-2007-970334
Scott TF, Yandora K, Kunschner LJ, Schramke C. Neurosarcoidosis mimicry of multiple sclerosis: clinical, laboratory, and imaging characteristics. Neurologist. 2010;16(6):386–9.
pubmed: 21150390
doi: 10.1097/NRL.0b013e3181b287df
Kirsten D. [Sarcoidosis in Germany. Analysis of a questionnaire survey in 1992 of patients of the German Sarcoidosis Group]. Pneumologie. 1995;49(6):378–82.
pubmed: 7644459
doi: 10.1055/s-2005-870910
Okumus G, Musellim B, Cetinkaya E, Turker H, Uzaslan E, Yenturk E, et al. Extrapulmonary involvement in patients with sarcoidosis in Turkey. Respirology. 2011;16(3):446–50.
pubmed: 20946338
doi: 10.1111/j.1440-1843.2010.01878.x
Send T, Tuleta I, Koppen T, Thiesler T, Eichhorn KW, Bertlich M, et al. Sarcoidosis of the paranasal sinuses. Eur Arch Otorhinolaryngol. 2019;276(7):1969–74.
pubmed: 30900021
doi: 10.1007/s00405-019-05388-7
Hoogendoorn JC, Ninaber MK, Piers SRD, de Riva M, Grauss RW, Bogun FM, et al. The harm of delayed diagnosis of arrhythmogenic cardiac sarcoidosis: a case series. Europace. 2020;22(9):1376–83.
pubmed: 32898252
pmcid: 7478317
doi: 10.1093/europace/euaa115
Judson MA, Thompson BW, Rabin DL, Steimel J, Knattereud GL, Lackland DT, et al. The diagnostic pathway to sarcoidosis. Chest. 2003;123(2):406–12.
pubmed: 12576358
doi: 10.1378/chest.123.2.406
Kobak S, Yildiz F, Semiz H, Orman M. Elderly-onset sarcoidosis: a single center comparative study. Reumatol Clin (Engl Ed). 2020;16(3):235–8.
pubmed: 30054252
doi: 10.1016/j.reuma.2018.06.004
Rodrigues MM, Coletta EN, Ferreira RG, Pereira CA. Delayed diagnosis of sarcoidosis is common in Brazil. J Bras Pneumol. 2013;39(5):539–46.
pubmed: 24310626
pmcid: 4075888
doi: 10.1590/S1806-37132013000500003
Sulkanen E, Repo M, Huhtala H, Hiltunen P, Kurppa K. Impact of diagnostic delay to the clinical presentation and associated factors in pediatric inflammatory bowel disease: a retrospective study. BMC Gastroenterol. 2021;21(1).
Namsrai T, Parkinson A, Chalmers A, Lowe C, Cook M, Phillips C, et al. Diagnostic delay of myositis: an integrated systematic review. Orphanet J Rare Dis. 2022;17(1):420.
pubmed: 36411487
pmcid: 9677896
doi: 10.1186/s13023-022-02570-9
Morgan J. Misdiagnosis of sarcoidosis. Lancet Respir Med. 2021;9(7):696–8.
pubmed: 33453759
doi: 10.1016/S2213-2600(21)00030-8
Desborough J, Brunoro C, Parkinson A, Chisholm K, Elisha M, Drew J, et al. It struck at the heart of who I thought I was’: a meta-synthesis of the qualitative literature examining the experiences of people with multiple sclerosis. Health Expect. 2020;23(5):1007–27.
pubmed: 32578287
pmcid: 7696124
doi: 10.1111/hex.13093
Voortman M, Hendriks CMR, Lodder P, Drent M, De Vries J. Quality of life of couples living with Sarcoidosis. Respiration. 2019;98(5):373–82.
pubmed: 31437834
doi: 10.1159/000501657
Zurynski Y, Deverell M, Dalkeith T et al. Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays. Orphanet J Rare Dis. 2017/04/11 2017;12(1):68. https://doi.org/10.1186/s13023-017-0622-4 .
Benito-Lozano J, Arias-Merino G, Gómez-Martínez M, Ancochea-Díaz A, Aparicio-García A, de la Posada M et al. Diagnostic process in Rare diseases: determinants Associated with Diagnostic Delay. Int J Environ Res Public Health. 2022;19(11).
Isono M, Kokado M, Kato K. Why does it take so long for rare disease patients to get an accurate diagnosis?—A qualitative investigation of patient experiences of hereditary angioedema. PLoS ONE. 2022;17(3):e0265847.
pubmed: 35303740
pmcid: 8932585
doi: 10.1371/journal.pone.0265847
Saketkoo LA, Russell AM, Jensen K, Mandizha J, Tavee J, Newton J et al. Health-Related Quality of Life (HRQoL) in Sarcoidosis: diagnosis, management, and Health outcomes. Diagnostics (Basel). 2021;11(6).
Baughman RP, Barriuso R, Beyer K, Boyd J, Hochreiter J, Knoet C, et al. Sarcoidosis: patient treatment priorities. ERJ Open Res. 2018;4(4):00141–2018.
pubmed: 30588477
pmcid: 6302206
doi: 10.1183/23120541.00141-2018